| 查看: 1885 | 回复: 57 | |||
| 【有奖交流】积极回复本帖子,参与交流,就有机会分得作者 chu_mouse 的 3 个金币 ,回帖就立即获得 1 个金币,每人有 1 次机会 | |||
[交流]
清华药学院储凌课题组招聘有机化学、化学生物学、生物方向博后及研究助理
|
|||
|
About the PI Ling Chu was born and raised in Hefei, Anhui, China. He received a B.S. degree in Chemistry from the University of Science and Technology of China in 2012. He completed his Ph.D. study at the Scripps Research Institute, where he conducted research with Prof. Jin-Quan Yu on the development of Palladium-catalyzed C-H activation reactions. After completing his Ph.D. in 2017, he switched his research field to chemical biology and worked with Prof. Alanna Schepartz and Prof. Derek Toomre as a Brown-Coxe postdoctoral fellow at Yale School of Medicine. In the Schepartz/Toomre lab, he developed new chemical biology tools for two-color long-time lapse live-cell super-resolution imaging. He then joined Prof. Craig Crews’ lab in 2019 as a postdoctoral associate, where he led the development of first PROTAC capable of degrading oncogenic KRASG12C. Ling will join School of Pharmaceutical Sciences, Tsinghua University as an assistant professor in 2021. His research interest lies at the interface of chemistry and biology. Website: chu-lab.org Email: chu_lab@126.com About the research New chemical biology tools to explore the beyond-rule-of-5 drug space There is an increasing need to pursuit less druggable targets that offer high potential for the development of new therapeutic agents and may require beyond-rule-of-5 (bRo5) molecules in order to take advantage of these opportunities. Nevertheless, bRo5 chemical space remains relatively unexplored, most likely due to the perceived non-oral properties, increased complexity of compounds in this space and the synthetic chemistry challenges associated with its navigation. There is a pressing need to develop new technologies for the discovery and oral delivery of bRo5 drugs. We will develop new chemical biology approaches that enable phenotypic screening of large, de novo bRo5 compound libraries inside living cells. Such efforts could potentially yield novel hits for “undruggable” targets. The strategies used here will be further pursued for applications in oral delivery of bRo5 compounds. Affecting protein stability as a new strategy to target KRAS The Kirsten rat sarcoma viral oncogene homologue (KRAS) gene is one of the most frequently mutated oncogenes in cancer. KRAS is mutated in ~30% of human cancers and is one of the most sought-after targets for pharmacological modulation. Despite its well-recognized importance in cancer malignancy, continuous efforts in the past three decades failed to develop approved therapies for KRAS mutant cancer. Recent efforts in direct targeting KRASG12C have resulted in small molecule inhibitors that showed great promise in early clinical trials. However, G12C mutant only represents a small percentage of patients with oncogenic KRAS mutations. To explore a general strategy to target KRAS, we will combine chemical screen and genetic screen to identify small molecules and genes that can destabilize KRAS across different mutant KRAS cell lines. Results from these screens will provide novel therapeutic leads and mechanistic insights of KRAS degradation pathway. Leveraging these findings, we hope to develop next-gen small molecule therapeutics for the treatment of KRAS mutant cancer. New tools for live-cell protein labeling and super-resolution imaging Proteins are the essential components in cell function. To understand the function of proteins in living cells, it is important to know the properties of proteins in the temporal and spatial context of the cell. Currently, live-cell protein labeling and imaging technologies have several limitations: 1) Widely adopted tools for live-cell protein labeling have a large size (20-30kDa), giving rise to concerns that they may interfere with protein folding, trafficking, activity, and interactions; 2) Fluorescence proteins or small molecule dyes bleach quickly under super-resolution imaging conditions, thus prevent long-term protein imaging. To solve these problems, we will develop short peptide tags for site-specific protein labeling in live cells. Such tags contain only a few amino acids and will have minimal perturbation of protein function in live cells. We will also develop bleaching-resistant live cell protein imaging tools that allow biologists to visualize the dynamics of proteins at the nanoscopy level (resolution<50 nm) with unlimited “photon budget”. Training We are an interdisciplinary research group working at the interface of chemistry and biology. Students in the lab will receive multidisciplinary training in experimental techniques ranging from synthetic chemistry to fluorescence microscopy to cellular studies. Representative skill sets in the group are given below. Chemical tools: organic synthesis, catalysts, medicinal chemistry, peptide synthesis Cell culture: mammalian cell lines, primary cell cultures Cell imaging: Confocal microscopy, STED, single-molecule microscopy, flow cytometry Molecular biology: Cloning, PCR, CRISPR Biochemistry: Protein purification, western blotting About the job We are actively recruiting. If you are passionate about chemical biology and drug discovery, come join us! Don’t hesitate to reach out to Dr. Chu at chu_lab@126.com Postdoc positions in biology Candidates should hold a PhD degree in cell biology, biochemistry, chemical biology, pharmacology or related fields. Experiences in phenotypic high-throughput assay or CRISPR screen are preferred but not required. If you are interested in joining the lab, please send your CV, research summary, and contact information of three referees to Dr. Chu at chu_lab@126.com. Postdoc positions in chemistry Candidates should hold a PhD degree in organic chemistry, medicinal chemistry or related fields. Experiences in transition-metal catalysts are preferred but not required. If you are interested in joining the lab, please send your CV, research summary, and contact information of three referees to Dr. Chu at chu_lab@126.com. Research assistants/Technicians Candidates should hold an MS or BS degree in chemistry or biology. If you are interested in joining the lab, please send your CV and contact information of three referees to Dr. Chu at chu_lab@126.com. Competitive salaries will be provided for qualified applicants. [ Last edited by chu_mouse on 2020-11-1 at 02:29 ] |
» 猜你喜欢
职称评审没过,求安慰
已经有49人回复
26申博自荐
已经有3人回复
A期刊撤稿
已经有4人回复
垃圾破二本职称评审标准
已经有17人回复
投稿Elsevier的Neoplasia杂志,到最后选publishing options时页面空白,不能完成投稿
已经有22人回复
EST投稿状态问题
已经有7人回复
毕业后当辅导员了,天天各种学生超烦
已经有4人回复
三无产品还有机会吗
已经有6人回复
» 抢金币啦!回帖就可以得到:
散给需要的人
+5/9485
郑州大学招收2026年外科学博士研究生
+1/462
双一流南京医科大学招计算机、AI、统计、生物信息等方向26年9月入学博士
+1/185
山东大学宋维业老师课题组招收光学、自动化控制、深度学习方向博士生
+1/177
Analytical Science Advances(Wiley出版社)长期征稿中...
+1/90
接样SEM/XPS/XRD/FTIR/BET等多种测试/提供预存服务
+1/86
中国科学院化学研究所招收2026级博士生
+5/85
国家青年人才叶立群教授课题组招收2026级博士研究生
+1/30
博士后招聘
+1/28
玩个游戏吧
+2/26
上海交通大学机械与动力工程学院周宝文博士后招聘(化学、材料与能源动力等方向)
+1/25
山东大学集成电路学院招收2026年9月入学的博士研究生
+1/16
中科院精密测量院(原武汉物数所)诚招磁共振成像方向申请考核制博士(2026.1.9截止)
+1/11
湖南师范大学分子识别与荧光传感团队招收2026年“申请-考核” 制博士研究生1名
+1/10
北理工柔性电子国家杰青团队招博士后及科研助理
+1/7
SCI,计算机相关可以写
+1/6
诚邀博士后合作研究人员
+1/4
求PDF卡片
+1/2
同济大学电信学院,肖李课题组招收2026年统考硕士生1-2名。
+1/1
中国科大电池方向任晓迪课题组招收2026级博士生-电解液/电池安全性/人工智能方向
+1/1
15楼2020-10-30 08:02:10
18楼2020-10-31 11:45:21
42楼2020-11-15 11:00:56
简单回复
TTTiger2楼
2020-10-29 10:55
回复
chu_mouse(金币+1): 谢谢参与
好 发自小木虫IOS客户端
tzynew3楼
2020-10-29 11:12
回复
chu_mouse(金币+1): 谢谢参与
8 发自小木虫Android客户端
tzynew4楼
2020-10-29 11:12
回复
tzynew5楼
2020-10-29 11:12
回复
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
icanspll7楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
howtoge8楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
yaqianye9楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
shehuifei10楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
zzhello11楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
likecitywo12楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
encryption13楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
ro1114楼
2020-10-29 12:50
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
DDDawn16楼
2020-10-30 13:55
回复
chu_mouse(金币+1): 谢谢参与
顶 发自小木虫IOS客户端
chu_mouse17楼
2020-10-31 10:54
回复
Haibo_19楼
2020-10-31 12:15
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
DDDawn20楼
2020-10-31 12:27
回复
psylhh21楼
2020-10-31 17:56
回复
chu_mouse(金币+1): 谢谢参与
chuwanglinyx22楼
2020-11-01 17:30
回复
chu_mouse23楼
2020-11-01 23:55
回复
chuwanglinyx24楼
2020-11-02 16:13
回复
chu_mouse25楼
2020-11-03 08:45
回复
chu_mouse26楼
2020-11-04 00:03
回复
chusihai27楼
2020-11-04 07:41
回复
chu_mouse28楼
2020-11-05 08:53
回复
chuwanglinyx29楼
2020-11-05 15:29
回复
chusihai30楼
2020-11-06 05:40
回复
chuwanglinyx31楼
2020-11-06 19:06
回复
chuwanglinyx32楼
2020-11-08 08:25
回复
chuwanglinyx33楼
2020-11-10 14:40
回复
chu_mouse34楼
2020-11-11 12:25
回复
chusihai35楼
2020-11-12 11:39
回复
chuwanglinyx36楼
2020-11-13 08:56
回复
chusihai37楼
2020-11-13 12:51
回复
蓉蓉番薯38楼
2020-11-13 18:31
回复
zhx202012339楼
2020-11-13 20:46
回复
chusihai40楼
2020-11-14 12:08
回复
zhx202012341楼
2020-11-15 07:00
回复
chuwanglinyx43楼
2020-11-16 10:31
回复
chu_mouse44楼
2020-11-16 11:09
回复
chusihai45楼
2020-11-17 06:09
回复
chuwanglinyx46楼
2020-11-17 15:28
回复
chusihai47楼
2020-11-18 06:03
回复
chu_mouse48楼
2020-11-19 11:34
回复
chusihai49楼
2020-11-19 22:57
回复
zhx202012350楼
2020-11-21 10:10
回复













回复此楼
